Monogram to Expand Oncology Franchise in '09 as '08 Revenues Rise 44 Percent
February 25, 2009
Monogram to Expand Oncology Franchise in '09 as '08 Revenues Rise 44 Percent
The company plans this year to add new markers to its HERmark breast cancer test, and will try to ink more collaborations with drug makers in order to embed its VeraTag assays in cancer drug trials.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- UK Startup DNA Electronics Developing Handheld Device to Detect Genetic Risk for Drug AEs
February 25, 2009 / Pharmacogenomics Reporter - Snippets
February 18, 2009 / Pharmacogenomics Reporter - MDx/CDx Focus: Siemens Inks Companion Dx Partnerships; FDA Accepts Roche's Pertuzumab BLA
February 8, 2012 / Pharmacogenomics Reporter - Monogram Biosciences' Q4 Revenues Rise 10 Percent
February 12, 2009 / GenomeWeb Daily News - Dx Assays Launches Fee-for-Service CDx Development Initiative Giving Pharma More Control
November 2, 2012 / Pharmacogenomics Reporter